• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿外泌体/微囊泡中的 microRNA-29c 作为肾纤维化的生物标志物。

MicroRNA-29c in urinary exosome/microvesicle as a biomarker of renal fibrosis.

机构信息

Institute of Nephrology, Zhongda Hospital School of Medicine, Southeast Univ., No. 87 Ding JiaQiao Rd., Nanjing, China 210009.

出版信息

Am J Physiol Renal Physiol. 2013 Oct 15;305(8):F1220-7. doi: 10.1152/ajprenal.00148.2013. Epub 2013 Aug 14.

DOI:10.1152/ajprenal.00148.2013
PMID:23946286
Abstract

Micro (mi)RNAs are frequently dysregulated in the development of renal fibrosis. Exosomes are small membrane vesicles that could be isolated from urine secreted from all nephron segments. Here we sought to observe for the first time whether miRNA in urine exosome could serve as a potential biomarker of renal fibrosis. Urine samples were collected from 32 chronic kidney disease (CKD) patients who underwent kidney biopsy and 7 controls. Exosome was isolated and confirmed by immunogold staining of exosome marker. Members of miR-29, miR-200, and RNU6B as endogenous control were detected by RT quantitative PCR. Electronic microscopy verified a typical shape of exosome with average size of 65.1 nm and labeled it with anti-CD9 and anti-aquaporin 2 antibody. Members of miR-29 and miR-200 are readily measured with reduced levels compared with controls (P < 0.05) and can robustly distinguish CKD from controls [area under the curve (AUC) varied from 0.902 to 1 by receiver operating characteristics analysis]. miR-29c correlated with both estimated glomerular filtration rate (r = 0.362; P < 0.05) and degree of tubulointerstitial fibrosis (r = -0.359; P < 0.05) for CKD patients. Moreover, miRNA in exosome was decreased in mild fibrosis group compared with moderated to severe group. miR-29a and miR-29c could predict degree of tubulointerstitial fibrosis with AUC of 0.883 and 0.738 (P < 0.05). The sensitivity and specificity for distinguishing mild from moderate to severe fibrosis were 93.8 and 81.3% with the use of miR-29a and 68.8 and 81.3% for miR-29c. Overall, miR-29c in urinary exosome correlates with both renal function and degree of histological fibrosis, suggesting it as a novel, noninvasive marker for renal fibrosis.

摘要

微小 RNA(miRNA)在肾纤维化的发展中经常失调。外泌体是可以从小鼠肾脏的尿液中分离出来的小膜泡。在这里,我们首次试图观察尿液外泌体中的 miRNA 是否可以作为肾纤维化的潜在生物标志物。收集了 32 名接受肾脏活检的慢性肾脏病(CKD)患者和 7 名对照者的尿液样本。通过对外泌体标志物的免疫金染色来分离和确认外泌体。通过 RT 定量 PCR 检测 miR-29、miR-200 和 RNU6B 作为内参。电子显微镜证实了外泌体的典型形状,平均尺寸为 65.1nm,并标记有抗 CD9 和抗水通道蛋白 2 抗体。与对照组相比,miR-29 和 miR-200 的成员易于测量,水平降低(P<0.05),并且可以可靠地区分 CKD 与对照组[通过接受者操作特征分析,曲线下面积(AUC)从 0.902 到 1 不等]。miR-29c 与 CKD 患者的估算肾小球滤过率(r=0.362;P<0.05)和肾小管间质纤维化程度(r=-0.359;P<0.05)相关。此外,与中度至重度纤维化组相比,轻度纤维化组中 exosome 的 miRNA 减少。miR-29a 和 miR-29c 可以预测肾小管间质纤维化的程度,AUC 分别为 0.883 和 0.738(P<0.05)。使用 miR-29a 区分轻度与中度至重度纤维化的敏感性和特异性分别为 93.8%和 81.3%,使用 miR-29c 分别为 68.8%和 81.3%。总体而言,尿外泌体中的 miR-29c 与肾功能和组织学纤维化程度相关,提示其为一种新的、非侵入性的肾纤维化标志物。

相似文献

1
MicroRNA-29c in urinary exosome/microvesicle as a biomarker of renal fibrosis.尿外泌体/微囊泡中的 microRNA-29c 作为肾纤维化的生物标志物。
Am J Physiol Renal Physiol. 2013 Oct 15;305(8):F1220-7. doi: 10.1152/ajprenal.00148.2013. Epub 2013 Aug 14.
2
miR-29c in urinary exosomes as predictor of early renal fibrosis in lupus nephritis.尿外泌体中的 miR-29c 作为狼疮性肾炎早期肾纤维化的预测因子。
Nephrol Dial Transplant. 2015 Sep;30(9):1488-96. doi: 10.1093/ndt/gfv128. Epub 2015 Jun 3.
3
A PEG-based method for the isolation of urinary exosomes and its application in renal fibrosis diagnostics using cargo miR-29c and miR-21 analysis.基于 PEG 的尿液外泌体分离方法及其在 cargo miR-29c 和 miR-21 分析用于肾纤维化诊断中的应用。
Int Urol Nephrol. 2018 May;50(5):973-982. doi: 10.1007/s11255-017-1779-4. Epub 2018 Jan 12.
4
Non-Proximal Renal Tubule-Derived Urinary Exosomal miR-200b as a Biomarker of Renal Fibrosis.非近端肾小管来源的尿细胞外囊泡 miR-200b 作为肾纤维化的生物标志物。
Nephron. 2018;139(3):269-282. doi: 10.1159/000487104. Epub 2018 Mar 14.
5
Liquid biopsy biomarkers of renal interstitial fibrosis based on urinary exosome.基于尿液外泌体的肾间质纤维化液体活检生物标志物。
Exp Mol Pathol. 2018 Oct;105(2):223-228. doi: 10.1016/j.yexmp.2018.08.004. Epub 2018 Aug 16.
6
Potential Value of Urinary Exosome-Derived let-7c-5p in the Diagnosis and Progression of Type II Diabetic Nephropathy.尿外泌体源性let-7c-5p在II型糖尿病肾病诊断及病情进展中的潜在价值
Clin Lab. 2018 May 1;64(5):709-718. doi: 10.7754/Clin.Lab.2018.171031.
7
Urinary exosomes derived circRNAs as biomarkers for chronic renal fibrosis.尿液外泌体来源的 circRNAs 作为慢性肾纤维化的生物标志物。
Ann Med. 2022 Dec;54(1):1966-1976. doi: 10.1080/07853890.2022.2098374.
8
Urinary miR-196a predicts disease progression in patients with chronic kidney disease.尿 microRNA-196a 可预测慢性肾脏病患者的疾病进展。
J Transl Med. 2018 Apr 10;16(1):91. doi: 10.1186/s12967-018-1470-2.
9
Urinary miR-21, miR-29, and miR-93: novel biomarkers of fibrosis.尿 microRNA-21、microRNA-29 和 microRNA-93:纤维化的新型生物标志物。
Am J Nephrol. 2012;36(5):412-8. doi: 10.1159/000343452. Epub 2012 Oct 27.
10
Plasma exosome microRNAs are indicative of breast cancer.血浆外泌体微小RNA可作为乳腺癌的指示物。
Breast Cancer Res. 2016 Sep 8;18(1):90. doi: 10.1186/s13058-016-0753-x.

引用本文的文献

1
Role of the TGF‑β/Smad signaling pathway in the transition from acute kidney injury to chronic kidney disease (Review).转化生长因子-β/信号转导和转录激活因子信号通路在急性肾损伤向慢性肾脏病转变中的作用(综述)
Int J Mol Med. 2025 Oct;56(4). doi: 10.3892/ijmm.2025.5603. Epub 2025 Aug 1.
2
Urinary Extracellular Vesicle Analysis Reveals Early Signs of Kidney Inflammation and Damage in Single Ventricle Paediatric Patients After Fontan Operation.尿液细胞外囊泡分析揭示了单心室儿科患者在Fontan手术后肾脏炎症和损伤的早期迹象。
Int J Nanomedicine. 2025 May 7;20:5907-5922. doi: 10.2147/IJN.S483534. eCollection 2025.
3
Extracellular Vesicles in Renal Inflammatory Diseases: Revealing Mechanisms of Extracellular Vesicle-Mediated Macrophage Regulation.
肾脏炎症性疾病中的细胞外囊泡:揭示细胞外囊泡介导的巨噬细胞调节机制
Int J Mol Sci. 2025 Apr 12;26(8):3646. doi: 10.3390/ijms26083646.
4
Emerging roles of exosomes in the diagnosis and treatment of kidney diseases.外泌体在肾脏疾病诊断和治疗中的新作用。
Front Pharmacol. 2025 Apr 16;16:1525314. doi: 10.3389/fphar.2025.1525314. eCollection 2025.
5
Emerging Frontiers in acute kidney injury: The role of extracellular vesicles.急性肾损伤的新兴前沿领域:细胞外囊泡的作用
Bioact Mater. 2025 Feb 18;48:149-170. doi: 10.1016/j.bioactmat.2025.02.018. eCollection 2025 Jun.
6
MicroRNA Nobel Prize: Timely Recognition and High Anticipation of Future Products-A Prospective Analysis.诺贝尔生理学或医学奖与微小RNA:及时认可与对未来产品的高度期待——前瞻性分析
Int J Mol Sci. 2024 Nov 29;25(23):12883. doi: 10.3390/ijms252312883.
7
New insights on genetic background of major diabetic vascular complications.关于主要糖尿病血管并发症遗传背景的新见解。
Diabetol Metab Syndr. 2024 Oct 7;16(1):243. doi: 10.1186/s13098-024-01473-y.
8
Panel miRNAs are potential diagnostic markers for chronic kidney diseases: a systematic review and meta-analysis.面板 miRNA 是慢性肾脏病的潜在诊断标志物:系统评价和荟萃分析。
BMC Nephrol. 2024 Aug 13;25(1):261. doi: 10.1186/s12882-024-03702-y.
9
Future embracing: exosomes driving a revolutionary approach to the diagnosis and treatment of idiopathic membranous nephropathy.拥抱未来:外泌体推动特发性膜性肾病诊断和治疗的革命性方法。
J Nanobiotechnology. 2024 Aug 8;22(1):472. doi: 10.1186/s12951-024-02633-y.
10
Exosomes on the development and progression of renal fibrosis.外泌体在肾纤维化发生发展中的作用。
Cell Prolif. 2024 Nov;57(11):e13677. doi: 10.1111/cpr.13677. Epub 2024 Jun 19.